Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00888914 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
A Phase 2 study of Facial Wrinkles and Lateral Canthal Lines, sponsored by Revance Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 4
- Study locations
NCT00888914: Completed Phase 2 study of Facial Wrinkles and Lateral Canthal Lines, sponsored by Revance Therapeutics.
NCT00888914 is a Phase 2 study of Facial Wrinkles and Lateral Canthal Lines that has completed, run by Revance Therapeutics. The registered enrollment target is 60 participants, below the 77-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (22% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00888914, a Phase 2 study of Facial Wrinkles and Lateral Canthal Lines, has completed, sponsored by Revance Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate to severe lateral canthal lines in adults.
Conditions Studied
Interventions
- DRUG RT001
- OTHER Vehicle Comparator
Study Locations (4)
New York
- Head and Neck Surgical Group - New York
- Aesthetic Plastic Surgery - New York
- Dermatology Surgery and Laser Center - White Plains
California
- Richard G. Glogau, MD - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
What the finished NCT00888914 record still lists
NCT00888914 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 77-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (22% lower).
The record links to 3 conditions, with Facial Wrinkles appearing as the primary indexed condition, and to 2 interventions - of which RT001 is the first listed.
NCT00888914 reports a single indexed study location in New York, California.
Frequently Asked Questions
What is clinical trial NCT00888914 about?
NCT00888914 is a clinical study titled "Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines". The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate to severe lateral canthal lines in adults.
What is the current status of trial NCT00888914?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2008-11. Estimated completion is 2009-02.
What conditions does trial NCT00888914 study?
This clinical trial studies the following conditions: Facial Wrinkles, Lateral Canthal Lines, Crows Feet.
What interventions are being tested in trial NCT00888914?
The interventions under investigation include: RT001 (DRUG), Vehicle Comparator (OTHER).
Who is sponsoring clinical trial NCT00888914?
This trial is sponsored by Revance Therapeutics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00888914 being conducted?
This trial has 4 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial Wrinkles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
Cryo-Touch II for the Treatment of Wrinkles
COMPLETED · Phase 2
-
A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
COMPLETED · Phase 2
-
Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles
COMPLETED · NA
-
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
COMPLETED · Phase 3
-
PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia